Editas Medicine underwrites 55.6M share offering with warrants

Editas Medicine is issuing 55,555,556 shares of common stock with accompanying warrants to purchase additional shares at $3.50 per share, through underwriters Cantor Fitzgerald and Wells Fargo Securities. The offering provides capital for the biotech company focused on gene editing therapeutics.